-
1
-
-
84919757874
-
-
US Department of Health and Human Services, Food and Drug Administration, Centre for Drug Evaluation and Research. Botanical Review Team (BRT). Available at of Medical ProductsandTobacco/CDER/ucm090973.htm [Accessed on 10 March 2014]
-
US Department of Health and Human Services, Food and Drug Administration, Centre for Drug Evaluation and Research. Botanical Review Team (BRT). Available at http://www.fda.gov/AboutFDA/CentersOffices/Office of Medical ProductsandTobacco/CDER/ucm090973.htm [Accessed on 10 March 2014]
-
-
-
-
2
-
-
0032488286
-
5300 years ago, the Ice Man used natural laxatives and antibiotics
-
COI: 1:STN:280:DyaK1M%2Fms1Onuw%3D%3D, PID: 9851424
-
Capasso L. 5300 years ago, the Ice Man used natural laxatives and antibiotics. Lancet 1998;352(9143):1864.
-
(1998)
Lancet
, vol.352
, Issue.9143
, pp. 1864
-
-
Capasso, L.1
-
3
-
-
0032508943
-
Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review
-
COI: 1:STN:280:DyaK1M%2Fjs1Wmsg%3D%3D, PID: 9820264
-
Wilt TJ, Ishani A, Stark G, MacDonald R, Lau J, Mulrow C. Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review. JAMA 1998;280:1604.
-
(1998)
JAMA
, vol.280
, pp. 1604
-
-
Wilt, T.J.1
Ishani, A.2
Stark, G.3
MacDonald, R.4
Lau, J.5
Mulrow, C.6
-
4
-
-
0037022799
-
Acupuncture: theory, efficacy, and practice
-
PID: 11874310
-
Kaptchuk TJ. Acupuncture: theory, efficacy, and practice. Ann Intern Med 2002;136:374.
-
(2002)
Ann Intern Med
, vol.136
, pp. 374
-
-
Kaptchuk, T.J.1
-
6
-
-
0022191565
-
Medicinal plants in therapy
-
COI: 1:STN:280:DyaL283hvVersQ%3D%3D, PID: 3879679
-
Farnsworth NR, Akerele O, Bingel AS, Soejarto DD, Guo Z. Medicinal plants in therapy. Bull World Health Organ 1985;63:965–981.
-
(1985)
Bull World Health Organ
, vol.63
, pp. 965-981
-
-
Farnsworth, N.R.1
Akerele, O.2
Bingel, A.S.3
Soejarto, D.D.4
Guo, Z.5
-
7
-
-
0032508952
-
Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey
-
COI: 1:STN:280:DyaK1M%2Fjs1WnsQ%3D%3D, PID: 9820257
-
Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, et al. Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. JAMA 1998;280:1569–1575.
-
(1998)
JAMA
, vol.280
, pp. 1569-1575
-
-
Eisenberg, D.M.1
Davis, R.B.2
Ettner, S.L.3
Appel, S.4
Wilkey, S.5
Van Rompay, M.6
-
8
-
-
0035899915
-
Herbal medicines today and the roots of modern pharmacology
-
COI: 1:CAS:528:DC%2BD3MXnvF2lsrY%3D, PID: 11601931
-
Goldman P. Herbal medicines today and the roots of modern pharmacology. Ann Intern Med 2001;135:594.
-
(2001)
Ann Intern Med
, vol.135
, pp. 594
-
-
Goldman, P.1
-
9
-
-
0037116642
-
Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey
-
PID: 11790213
-
Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell A. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA 2002;287:337.
-
(2002)
JAMA
, vol.287
, pp. 337
-
-
Kaufman, D.W.1
Kelly, J.P.2
Rosenberg, L.3
Anderson, T.E.4
Mitchell, A.5
-
10
-
-
33845863676
-
Patient initiation of complementary and alternative medical therapies (CAM) following cancer diagnosis
-
PID: 17207316
-
Vapiwala N, Mick R, Hampshire MK, Metz JM, DeNittis AS. Patient initiation of complementary and alternative medical therapies (CAM) following cancer diagnosis. Cancer J 2006;12:467–474.
-
(2006)
Cancer J
, vol.12
, pp. 467-474
-
-
Vapiwala, N.1
Mick, R.2
Hampshire, M.K.3
Metz, J.M.4
DeNittis, A.S.5
-
11
-
-
0032535678
-
The persuasive appeal of alternative medicine
-
COI: 1:STN:280:DyaK1M%2FmsVynuw%3D%3D, PID: 9867762
-
Kaptchuk TJ, Eisenberg DM. The persuasive appeal of alternative medicine. Ann Intern Med 1998;129:1061.
-
(1998)
Ann Intern Med
, vol.129
, pp. 1061
-
-
Kaptchuk, T.J.1
Eisenberg, D.M.2
-
12
-
-
0037137578
-
Botanical medicines-the need for new regulations
-
PID: 12490692
-
Marcus DM, Grollman AP. Botanical medicines-the need for new regulations. N Engl J Med 2002;347:2073.
-
(2002)
N Engl J Med
, vol.347
, pp. 2073
-
-
Marcus, D.M.1
Grollman, A.P.2
-
13
-
-
27844474247
-
Drug discovery from medicinal plants
-
COI: 1:CAS:528:DC%2BD2MXht1ejsrbP, PID: 16198377
-
Balunas MJ and Kinghorn AD. Drug discovery from medicinal plants. Life Sci 2005;78:431–441.
-
(2005)
Life Sci
, vol.78
, pp. 431-441
-
-
Balunas, M.J.1
Kinghorn, A.D.2
-
14
-
-
34249700741
-
Challenges and opportunities in drug discovery from plants
-
Jachak SM, Saklani A. Challenges and opportunities in drug discovery from plants. Current Sci 2007;92(9):7.
-
(2007)
Current Sci
, vol.92
, Issue.9
, pp. 7
-
-
Jachak, S.M.1
Saklani, A.2
-
15
-
-
57249086242
-
Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States
-
PID: 18955056
-
Chalasani N, Fontana RJ, Bonkovsky HL, Watkins PB, Davern T, Serrano J, et al. Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology 2008;135:1924.
-
(2008)
Gastroenterology
, vol.135
, pp. 1924
-
-
Chalasani, N.1
Fontana, R.J.2
Bonkovsky, H.L.3
Watkins, P.B.4
Davern, T.5
Serrano, J.6
-
16
-
-
53649089738
-
New therapies from old medicines
-
COI: 1:CAS:528:DC%2BD1cXht1aisrrP, PID: 18846070
-
Chen ST, Dou JH, Temple R, Agarwal R, Wu KM, Walker S. New therapies from old medicines. Nat Biotechnol 2008;26:1077–1083.
-
(2008)
Nat Biotechnol
, vol.26
, pp. 1077-1083
-
-
Chen, S.T.1
Dou, J.H.2
Temple, R.3
Agarwal, R.4
Wu, K.M.5
Walker, S.6
-
17
-
-
70449133964
-
Herbal and dietary supplement hepatotoxicity
-
COI: 1:CAS:528:DC%2BD1MXhtl2ksL3J, PID: 19826971
-
Navarro VJ. Herbal and dietary supplement hepatotoxicity. Semin Liver Dis 2009;29:373.
-
(2009)
Semin Liver Dis
, vol.29
, pp. 373
-
-
Navarro, V.J.1
-
18
-
-
77955709559
-
Satyahari Dey. Herbal drugs: standards and regulation
-
Niharika S, Padmavati M, Satyahari Dey. Herbal drugs: standards and regulation. Fitoterapia 81:462–471.
-
Fitoterapia
, vol.81
, pp. 462-471
-
-
Niharika, S.1
Padmavati, M.2
-
20
-
-
84876533957
-
SlimQuick?-associated hepatotoxicity in a woman with alpha-1 antitrypsin heterozygosity
-
PID: 22567188
-
Weinstein DH, Twaddell WS, Raufman JP, Philosophe B, Mindikoglu AL. SlimQuick?-associated hepatotoxicity in a woman with alpha-1 antitrypsin heterozygosity. World J Hepatol 2012;4:154.
-
(2012)
World J Hepatol
, vol.4
, pp. 154
-
-
Weinstein, D.H.1
Twaddell, W.S.2
Raufman, J.P.3
Philosophe, B.4
Mindikoglu, A.L.5
-
21
-
-
0036318997
-
Challenges and opportunities confronting the botanical dietary supplement industry
-
COI: 1:CAS:528:DC%2BD38XkvVGhs7c%3D, PID: 12141880
-
Cardellina JH II. Challenges and opportunities confronting the botanical dietary supplement industry. J Nat Prod 2002;65:1073–1084.
-
(2002)
J Nat Prod
, vol.65
, pp. 1073-1084
-
-
Cardellina, J.H.1
-
22
-
-
0033547648
-
Second thoughts about safety of St John’s wort
-
COI: 1:STN:280:DC%2BD3c7gtVeitA%3D%3D, PID: 10636361
-
Ernst E. Second thoughts about safety of St John’s wort. Lancet 1999;354:2014–2016.
-
(1999)
Lancet
, vol.354
, pp. 2014-2016
-
-
Ernst, E.1
-
23
-
-
0027512619
-
Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs
-
COI: 1:STN:280:DyaK3s7ls1Cquw%3D%3D, PID: 8094166
-
Vanherweghem JL, Depierreux M, Tielemans C, Abramowicz D, Dratwa M, Jadoul M, et al. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet 1993;341:387–391.
-
(1993)
Lancet
, vol.341
, pp. 387-391
-
-
Vanherweghem, J.L.1
Depierreux, M.2
Tielemans, C.3
Abramowicz, D.4
Dratwa, M.5
Jadoul, M.6
-
24
-
-
0027984677
-
Pathologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs
-
COI: 1:STN:280:DyaK2czisVekuw%3D%3D, PID: 8048421
-
Depierreux M, Van Damme B, Vanden Houte K, Vanherweghem JL. Pathologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs. Am J Kidney Dis 1994;24:172–180.
-
(1994)
Am J Kidney Dis
, vol.24
, pp. 172-180
-
-
Depierreux, M.1
Van Damme, B.2
Vanden Houte, K.3
Vanherweghem, J.L.4
-
25
-
-
0031900840
-
Use of herbal medicines among consultation-liaison populations. A review of current information regarding risks, interactions, and efficacy
-
Crone CC, Wise TN. Use of herbal medicines among consultation-liaison populations. A review of current information regarding risks, interactions, and efficacy. Psychosomatics 1998;39:43.
-
(1998)
Psychosomatics
, vol.39
, pp. 43
-
-
Crone, C.C.1
Wise, T.N.2
-
27
-
-
77949424056
-
Approaches to quality plant basedmedicine: significance of chemical profiling
-
Verpoorte R, (ed), Springer, Netherlands:
-
Saxena PK, Cole IB, Murch SJ. Approaches to quality plant basedmedicine: significance of chemical profiling. In: Verpoorte R, et al, eds. Applications of plant metabolic engineering. Netherlands: Springer; 2007:311.
-
(2007)
Applications of plant metabolic engineering
, pp. 311
-
-
Saxena, P.K.1
Cole, I.B.2
Murch, S.J.3
-
28
-
-
14444285482
-
Neuropharmacology of St. John’s Wort (Hypericum)
-
PID: 9825087
-
Bennett DA Jr1, Phun L, Polk JF, Voglino SA, Zlotnik V, Raffa RB. Neuropharmacology of St. John’s Wort (Hypericum). Ann Pharmacother 1998;32:1201.
-
(1998)
Ann Pharmacother
, vol.32
, pp. 1201
-
-
Bennett, D.A.1
Phun, L.2
Polk, J.F.3
Voglino, S.A.4
Zlotnik, V.5
Raffa, R.B.6
-
29
-
-
0031780096
-
Hyperforin represents the neurotransmitter reuptake inhibiting constituent of hypericum extract
-
PID: 9684943
-
Müller WE, Singer A, Wonnemann M, Hafner U, Rolli M, Schäfer C. Hyperforin represents the neurotransmitter reuptake inhibiting constituent of hypericum extract. Pharmacopsychiatry 1998;31Suppl 1:16.
-
(1998)
Pharmacopsychiatry
, vol.31
, pp. 16
-
-
Müller, W.E.1
Singer, A.2
Wonnemann, M.3
Hafner, U.4
Rolli, M.5
Schäfer, C.6
-
30
-
-
0032797512
-
Hyperforin, a major antidepressant constituent of St. John’s Wort, inhibits serotonin uptake by elevating free intracellular Na+1
-
COI: 1:CAS:528:DyaK1MXlsVOqtL8%3D
-
Singer A, Wonnemann M, Müller WE. Hyperforin, a major antidepressant constituent of St. John’s Wort, inhibits serotonin uptake by elevating free intracellular Na+1. J Pharm Exp Thera 1999;290:1363.
-
(1999)
J Pharm Exp Thera
, vol.290
, pp. 1363
-
-
Singer, A.1
Wonnemann, M.2
Müller, W.E.3
-
31
-
-
0037463827
-
Echinacea and truth in labeling
-
Gilroy CM, Steiner JF, Byers T, Shapiro H, Georgian W. Echinacea and truth in labeling. Arch Int Med 2003;163:699.
-
(2003)
Arch Int Med
, vol.163
, pp. 699
-
-
Gilroy, C.M.1
Steiner, J.F.2
Byers, T.3
Shapiro, H.4
Georgian, W.5
-
32
-
-
0034982633
-
Variability in commercial ginseng products: an analysis of 25 preparations
-
COI: 1:CAS:528:DC%2BD3MXktlWhsrY%3D
-
Harkey MR, Henderson GL, Gershwin ME, Stern JS, Hackman RM. Variability in commercial ginseng products: an analysis of 25 preparations. Am J Clin Nut 2001;73:1101–1106.
-
(2001)
Am J Clin Nut
, vol.73
, pp. 1101-1106
-
-
Harkey, M.R.1
Henderson, G.L.2
Gershwin, M.E.3
Stern, J.S.4
Hackman, R.M.5
-
33
-
-
0141765788
-
Drug-herb interaction among commonly used conventional medicines: a compendium for health care professionals
-
Brazier NC and Levine MA. Drug-herb interaction among commonly used conventional medicines: a compendium for health care professionals. Am J Thera 2003;10:163.
-
(2003)
Am J Thera
, vol.10
, pp. 163
-
-
Brazier, N.C.1
Levine, M.A.2
-
34
-
-
0041530157
-
High prevalence of potentially hepatotoxic herbal supplement use in patients with fulminant hepatic failure
-
PID: 12912743
-
Estes JD, Stolpman D, Olyaei A, Corless CL, Ham JM, Schwartz JM, et al. High prevalence of potentially hepatotoxic herbal supplement use in patients with fulminant hepatic failure. Arch Surg 2003;138:852.
-
(2003)
Arch Surg
, vol.138
, pp. 852
-
-
Estes, J.D.1
Stolpman, D.2
Olyaei, A.3
Corless, C.L.4
Ham, J.M.5
Schwartz, J.M.6
-
35
-
-
84867531046
-
Evaluation of documented drug interactions and contraindications associated with herbs and dietary supplements: a systematic literature review
-
COI: 1:CAS:528:DC%2BC3sXitVyrug%3D%3D, PID: 23067030
-
Tsai HH, Lin HW, Pickard AS, Tsai HY, Mahady GB. Evaluation of documented drug interactions and contraindications associated with herbs and dietary supplements: a systematic literature review. Int J Clin Pract 2012;66:1056–1078.
-
(2012)
Int J Clin Pract
, vol.66
, pp. 1056-1078
-
-
Tsai, H.H.1
Lin, H.W.2
Pickard, A.S.3
Tsai, H.Y.4
Mahady, G.B.5
-
36
-
-
29144526737
-
Herb and supplement use in the US adult population
-
PID: 16368456
-
Kennedy J. Herb and supplement use in the US adult population. Clin Ther 2005;27:1847.
-
(2005)
Clin Ther
, vol.27
, pp. 1847
-
-
Kennedy, J.1
-
37
-
-
33644776667
-
Hepatotoxicity associated with supplements containing Chinese green tea (Camellia sinensis)
-
PID: 16389263
-
Bonkovsky HL. Hepatotoxicity associated with supplements containing Chinese green tea (Camellia sinensis). Ann Intern Med 2006;144:68.
-
(2006)
Ann Intern Med
, vol.144
, pp. 68
-
-
Bonkovsky, H.L.1
-
38
-
-
33745727273
-
Hepatotoxicity due to extracts of Chinese green tea (Camellia sinensis): a growing concern
-
COI: 1:CAS:528:DC%2BD28Xmslylu7g%3D, PID: 16793166
-
Javaid A, Bonkovsky HL. Hepatotoxicity due to extracts of Chinese green tea (Camellia sinensis): a growing concern. J Hepatol 2006;45:334.
-
(2006)
J Hepatol
, vol.45
, pp. 334
-
-
Javaid, A.1
Bonkovsky, H.L.2
-
39
-
-
33845473093
-
Acute liver failure induced by green tea extracts: case report and review of the literature
-
PID: 17133573
-
Molinari M, Watt KD, Kruszyna T, Nelson R, Walsh M, Huang WY, et al. Acute liver failure induced by green tea extracts: case report and review of the literature. Liver Transpl 2006;12:1892.
-
(2006)
Liver Transpl
, vol.12
, pp. 1892
-
-
Molinari, M.1
Watt, K.D.2
Kruszyna, T.3
Nelson, R.4
Walsh, M.5
Huang, W.Y.6
-
40
-
-
0034639643
-
Indinavir concentrations and St John’s wort
-
COI: 1:CAS:528:DC%2BD3cXhs1elsbs%3D, PID: 10683007
-
Piscitelli SC, Burstein AH, Chaitt D, Alfaro RM, Falloon J. Indinavir concentrations and St John’s wort. Lancet 2000;355:547–548.
-
(2000)
Lancet
, vol.355
, pp. 547-548
-
-
Piscitelli, S.C.1
Burstein, A.H.2
Chaitt, D.3
Alfaro, R.M.4
Falloon, J.5
-
41
-
-
13244295315
-
Adverse effects of St. John’s Wort: a systematic review
-
Knüppel L and Linde K. Adverse effects of St. John’s Wort: a systematic review. J Clin Psych 2004;65:1470.
-
(2004)
J Clin Psych
, vol.65
, pp. 1470
-
-
Knüppel, L.1
Linde, K.2
-
42
-
-
0000006828
-
Pharmacokinetic interaction of digoxin with an herbal extract from St John’s wort (Hypericum perforatum)
-
COI: 1:CAS:528:DyaK1MXntlWiu7o%3D, PID: 10546917
-
Johne A, Brockmöller J, Bauer S, Maurer A, Langheinrich M, Roots I. Pharmacokinetic interaction of digoxin with an herbal extract from St John’s wort (Hypericum perforatum). Clin Pharmacol Ther 1999;66:338–345.
-
(1999)
Clin Pharmacol Ther
, vol.66
, pp. 338-345
-
-
Johne, A.1
Brockmöller, J.2
Bauer, S.3
Maurer, A.4
Langheinrich, M.5
Roots, I.6
-
43
-
-
0034691064
-
St. John’s wort induces hepatic drug metabolism through activation of the pregnane X receptor
-
COI: 1:CAS:528:DC%2BD3cXksVKhs7s%3D, PID: 10852961
-
Moore LB, Goodwin B, Jones SA, Wisely GB, Serabjit-Singh CJ, Willson TM, et al. St. John’s wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc Natl Acad Sci USA. 2000;97:7500–7502.
-
(2000)
Proc Natl Acad Sci USA
, vol.97
, pp. 7500-7502
-
-
Moore, L.B.1
Goodwin, B.2
Jones, S.A.3
Wisely, G.B.4
Serabjit-Singh, C.J.5
Willson, T.M.6
-
44
-
-
0035652201
-
Different effects of St John’s wort on the pharmacokinetics of simvastatin and pravastatin
-
COI: 1:CAS:528:DC%2BD38XmtVCkuw%3D%3D, PID: 11753267
-
Sugimoto K, Ohmori M, Tsuruoka S, Nishiki K, Kawaguchi A, Harada K, et al. Different effects of St John’s wort on the pharmacokinetics of simvastatin and pravastatin. Clin Pharmacol Ther 2001;70:518–524.
-
(2001)
Clin Pharmacol Ther
, vol.70
, pp. 518-524
-
-
Sugimoto, K.1
Ohmori, M.2
Tsuruoka, S.3
Nishiki, K.4
Kawaguchi, A.5
Harada, K.6
-
45
-
-
0037151365
-
Effects of St. John’s wort on irinotecan metabolism
-
COI: 1:CAS:528:DC%2BD38XntVyjsL8%3D, PID: 12189228
-
Mathijssen RH, Verweij J, de Bruijn P, Loos WJ, Sparreboom A, et al. Effects of St. John’s wort on irinotecan metabolism. J Natl Cancer Inst 2002;94:1247–1249.
-
(2002)
J Natl Cancer Inst
, vol.94
, pp. 1247-1249
-
-
Mathijssen, R.H.1
Verweij, J.2
de Bruijn, P.3
Loos, W.J.4
Sparreboom, A.5
-
46
-
-
30844472028
-
The extent of induction of CYP3A by St. John’s wort varies among products and is linked to hyperforin dose
-
COI: 1:CAS:528:DC%2BD28XksVOlug%3D%3D, PID: 16341856
-
Mueller SC, Majcher-Peszynska J, Uehleke B, Klammt S, Mundkowski RG, Miekisch W, et al. The extent of induction of CYP3A by St. John’s wort varies among products and is linked to hyperforin dose. Eur J Clin Pharmacol 2006;62:29–36.
-
(2006)
Eur J Clin Pharmacol
, vol.62
, pp. 29-36
-
-
Mueller, S.C.1
Majcher-Peszynska, J.2
Uehleke, B.3
Klammt, S.4
Mundkowski, R.G.5
Miekisch, W.6
-
47
-
-
58649102491
-
Reduced efficacy of rosuvastatin by St. John’s Wort
-
PID: 19185075
-
Gordon RY, Becker DJ, Rader DJ. Reduced efficacy of rosuvastatin by St. John’s Wort. Am J Med 2009;122:e1.
-
(2009)
Am J Med
, vol.122
, pp. e1
-
-
Gordon, R.Y.1
Becker, D.J.2
Rader, D.J.3
-
48
-
-
77956057096
-
St John’s wort greatly reduces the concentrations of oral oxycodone
-
COI: 1:CAS:528:DC%2BC3cXhtVGmurnF, PID: 20106684
-
Nieminen TH, Hagelberg NM, Saari TI, Neuvonen M, Laine K, Neuvonen PJ, et al. St John’s wort greatly reduces the concentrations of oral oxycodone. Eur J Pain 2010;14:854–859.
-
(2010)
Eur J Pain
, vol.14
, pp. 854-859
-
-
Nieminen, T.H.1
Hagelberg, N.M.2
Saari, T.I.3
Neuvonen, M.4
Laine, K.5
Neuvonen, P.J.6
-
49
-
-
0035953135
-
Americans’ views on the use and regulation of dietary supplements
-
COI: 1:STN:280:DC%2BD3M3mtVeltg%3D%3D, PID: 11268222
-
Blendon RJ, DesRoches CM, Benson JM, Brodie M, Altman DE. Americans’ views on the use and regulation of dietary supplements. Arch Intern Med 2001;161:805–810.
-
(2001)
Arch Intern Med
, vol.161
, pp. 805-810
-
-
Blendon, R.J.1
DesRoches, C.M.2
Benson, J.M.3
Brodie, M.4
Altman, D.E.5
-
50
-
-
42549101465
-
Patient use of dietary supplements: a clinician’s perspective
-
PID: 18348745
-
Sadovsky R, Collins N, Tighe AP, Brunton SA, Safeer R. Patient use of dietary supplements: a clinician’s perspective. Curr Med Res Opin. 2008;24:1209–1216.
-
(2008)
Curr Med Res Opin
, vol.24
, pp. 1209-1216
-
-
Sadovsky, R.1
Collins, N.2
Tighe, A.P.3
Brunton, S.A.4
Safeer, R.5
-
51
-
-
77953686918
-
How physicians should evaluate dietary supplements
-
PID: 20493463
-
Glisson JK, Walker LA. How physicians should evaluate dietary supplements. Am J Med 2010;123:577–582.
-
(2010)
Am J Med
, vol.123
, pp. 577-582
-
-
Glisson, J.K.1
Walker, L.A.2
-
52
-
-
84055184876
-
Convergence: where West meets East
-
Peng T. Convergence: where West meets East. Nature 2011;480:S84–S86.
-
(2011)
Nature
, vol.480
, pp. S84-S86
-
-
Peng, T.1
-
53
-
-
72049128937
-
Centre turns away from healing herbs
-
Wadman M. Centre turns away from healing herbs. Nature News. 2009;7. Doi:10.1038/462711a. Published online 07 December 2009
-
(2009)
Nature News
, pp. 7
-
-
Wadman, M.1
-
54
-
-
47149089182
-
Current regulatory toxicology perspectives on the development of herbal medicines to prescription drug products in the United States
-
COI: 1:CAS:528:DC%2BD1cXoslCns70%3D, PID: 18614266
-
Wu KM, Ghantous H, Birnkrant DB. Current regulatory toxicology perspectives on the development of herbal medicines to prescription drug products in the United States. Food Chem Toxicol 2008;46:2606–2610.
-
(2008)
Food Chem Toxicol
, vol.46
, pp. 2606-2610
-
-
Wu, K.M.1
Ghantous, H.2
Birnkrant, D.B.3
-
55
-
-
77649222572
-
Molecular predictors of outcome with gefitinib and docetaxel in previously treated non-small-ell lung cancer: data from the randomized phase III INTEREST trial
-
COI: 1:CAS:528:DC%2BC3cXksVyrsbY%3D, PID: 20038723
-
Douillard JY, Shepherd FA, Hirsh V, Mok T, Socinski MA, Gervais R, et al. Molecular predictors of outcome with gefitinib and docetaxel in previously treated non-small-ell lung cancer: data from the randomized phase III INTEREST trial. J Clin Oncol 2010;28:744–752.
-
(2010)
J Clin Oncol
, vol.28
, pp. 744-752
-
-
Douillard, J.Y.1
Shepherd, F.A.2
Hirsh, V.3
Mok, T.4
Socinski, M.A.5
Gervais, R.6
-
56
-
-
2342471392
-
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
-
COI: 1:CAS:528:DC%2BD2cXktF2js7c%3D, PID: 15118073
-
Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Brannigan BW, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 2004;350:2129–2139.
-
(2004)
N Engl J Med
, vol.350
, pp. 2129-2139
-
-
Lynch, T.J.1
Bell, D.W.2
Sordella, R.3
Gurubhagavatula, S.4
Okimoto, R.A.5
Brannigan, B.W.6
-
57
-
-
2342624080
-
EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy
-
COI: 1:CAS:528:DC%2BD2cXksVGmsbs%3D, PID: 15118125
-
Paez JG, Jänne PA, Lee JC, Tracy S, Greulich H, Gabriel S, et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 2004;304:1497–1500.
-
(2004)
Science
, vol.304
, pp. 1497-1500
-
-
Paez, J.G.1
Jänne, P.A.2
Lee, J.C.3
Tracy, S.4
Greulich, H.5
Gabriel, S.6
-
58
-
-
70350152573
-
Systems biology guided by Chinese medicine reveals new markers for sub-typing rheumatoid arthritis patients
-
PID: 20009967
-
van Wietmarschen HA, Yuan K, Lu C, Gao P, Wang J, Xiao C, et al. Systems biology guided by Chinese medicine reveals new markers for sub-typing rheumatoid arthritis patients. J Clin Rheumatol 2009;15:330–337
-
(2009)
J Clin Rheumatol
, vol.15
, pp. 330-337
-
-
van Wietmarschen, H.A.1
Yuan, K.2
Lu, C.3
Gao, P.4
Wang, J.5
Xiao, C.6
-
59
-
-
80052843185
-
Sub-typing of rheumatic diseases based on a systems diagnosis questionnaire
-
PID: 21949766
-
van Wietmarschen HA, Reijmers TH, van der Kooij AJ, Schroën J, Wei H, Hankemeier T, et al. Sub-typing of rheumatic diseases based on a systems diagnosis questionnaire. PLoS One 2011;6:e24846.
-
(2011)
PLoS One
, vol.6
, pp. e24846
-
-
van Wietmarschen, H.A.1
Reijmers, T.H.2
van der Kooij, A.J.3
Schroën, J.4
Wei, H.5
Hankemeier, T.6
-
60
-
-
84866316346
-
Characterization of rheumatoid arthritis subtypes using symptom profiles, clinical chemistry and metabolomics measurements
-
PID: 22984493
-
van Wietmarschen HA, Dai W, van der Kooij AJ, Reijmers TH, Schroën Y, Wang M, et al. Characterization of rheumatoid arthritis subtypes using symptom profiles, clinical chemistry and metabolomics measurements. PLoS One 2012;7:e44331.
-
(2012)
PLoS One
, vol.7
, pp. e44331
-
-
van Wietmarschen, H.A.1
Dai, W.2
van der Kooij, A.J.3
Reijmers, T.H.4
Schroën, Y.5
Wang, M.6
-
61
-
-
28844463093
-
Statin use in a “real-world” clinical setting: aggressive lipid lowering compared with usual care in the Aggressive Lipid-Lowering Initiation Abates New Cardiac Events (ALLIANCE) trial
-
PID: 16356803
-
Koren MJ. Statin use in a “real-world” clinical setting: aggressive lipid lowering compared with usual care in the Aggressive Lipid-Lowering Initiation Abates New Cardiac Events (ALLIANCE) trial. Am J Med 2005;118Suppl:16–21.
-
(2005)
Am J Med
, vol.118
, pp. 16-21
-
-
Koren, M.J.1
-
62
-
-
33644884271
-
Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement
-
PID: 16520478
-
Gagnier JJ, Boon H, Rochon P, Moher D, Barnes J, Bombardier C. Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement. Ann Intern Med 2006;144:364–367.
-
(2006)
Ann Intern Med
, vol.144
, pp. 364-367
-
-
Gagnier, J.J.1
Boon, H.2
Rochon, P.3
Moher, D.4
Barnes, J.5
Bombardier, C.6
|